Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIBRETTO: Stimulan Local Antibiotic Delivery vs 4-Week Systemic Antibiotics for Diabetic Foot Osteomyelitis
2025-524723-52-00Phase 3Authorised
- Sponsor
- Pirkanmaan hyvinvointialue
- Start
- Apr 2026
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of STIMULAN in diabetic foot osteomyelitis (DFO) (2 arms), sponsored by Pirkanmaan hyvinvointialue. Primary endpoints: Healed ulcer/osteomyelitis resolution at 12 weeks and Healed ulcer/osteomyelitis resolution at 24 weeks. Planned start Apr 2026; status: authorised.
02
Drugs
STIMULAN
03
Conditions
diabetic foot osteomyelitis (DFO)
Beyond the preview
Go deeper on 2025-524723-52-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524723-52-00.